UBS Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.69K | Sell |
|
|||||
|
2025
Q2 | $33.1K | Sell |
|
|||||
|
2025
Q1 | $11.6K | Hold |
|
|||||
|
2024
Q4 | $15K | Buy |
|
|||||
|
2024
Q3 | $3.31K | Sell |
|
|||||
|
2024
Q2 | $38.3K | Buy |
|
|||||
|
2024
Q1 | $29.3K | Buy |
|
|||||
|
2023
Q4 | $10.9K | Sell |
|
|||||
|
2023
Q3 | $34.5K | Buy |
|
|||||
|
2023
Q2 | $127K | Sell |
|
|||||
|
2023
Q1 | $158K | Sell |
|
|||||
|
2022
Q4 | $177K | Sell |
|
|||||
|
2022
Q3 | $496K | Buy |
|
|||||
|
2022
Q2 | $333K | Sell |
|
|||||
|
2022
Q1 | $218K | Sell |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $1.33M | Buy |
|
|||||
|
2021
Q2 | $938K | Sell |
|
|||||
|
2021
Q1 | $2.58M | Buy |
|
|||||
|
2020
Q4 | $1.02M | Sell |
|
|||||
|
2020
Q3 | $1.12M | Sell |
|
|||||
|
2020
Q2 | $1.82M | Sell |
|
|||||
|
2020
Q1 | $1.58M | Sell |
|
|||||
|
2019
Q4 | $3.26M | Sell |
|
|||||
|
2019
Q3 | $4.05M | Buy |
|
|||||
|
2019
Q2 | $3.23M | Buy |
|
|||||
|
2019
Q1 | $1.78M | Sell |
|
|||||
|
2018
Q4 | $1.42M | Buy |
|
|||||
|
2018
Q3 | $1.63M | Sell |
|
|||||
|
2018
Q2 | $1.63M | Sell |
|
|||||
|
2018
Q1 | $3.42M | Buy |
|
|||||
|
2017
Q4 | $2.67M | Sell |
|
|||||
|
2017
Q3 | $4.21M | Buy |
|
|||||
|
2017
Q2 | $4.11M | Buy |
|
|||||
|
2017
Q1 | $4M | Sell |
|
|||||
|
2016
Q4 | $4.36M | Buy |
|
|||||
|
2016
Q3 | $3.46M | Sell |
|
|||||
|
2016
Q2 | $3.86M | Buy |
|
|||||
|
2016
Q1 | $4.3M | Sell |
|
|||||
|
2015
Q4 | $7.52M | Buy |
|
|||||
|
2015
Q3 | $4.85M | Buy |
|
|||||
|
2015
Q2 | $4.7M | Buy |
|
|||||
|
2015
Q1 | $4.05M | Buy |
|
|||||
|
2014
Q4 | $1.56M | Buy |
|